BP
Broadleaf Partners Portfolio holdings
AUM
$454M
This Quarter Return
-6.77%
1 Year Return
+28.74%
3 Year Return
+156.4%
5 Year Return
+247.26%
10 Year Return
–
AUM
$382M
AUM Growth
+$382M
(-11%)
Cap. Flow
-$14.6M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
45.56%
Holding
85
New
8
Increased
11
Reduced
42
Closed
6
Top Buys
| 1 |
Broadcom
AVGO
|
$6.12M |
| 2 |
Tesla
TSLA
|
$4.48M |
| 3 |
Cintas
CTAS
|
$3.38M |
| 4 |
JPMorgan Chase
JPM
|
$3.33M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$3.12M |
Top Sells
| 1 |
Trade Desk
TTD
|
$10.7M |
| 2 |
Eli Lilly
LLY
|
$5.95M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$5.3M |
| 4 |
TransDigm Group
TDG
|
$3.96M |
| 5 |
Netflix
NFLX
|
$3.59M |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Communication Services | 11.8% |
| 3 | Consumer Discretionary | 11.49% |
| 4 | Financials | 11.18% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertiv
VRT
$47.4B
| $5.12M | 1.34% |
70,948
-1,375
| -2% | -$99.3K |
|
27
Schwab US Dividend Equity ETF
SCHD
$72.3B
| $4.83M | 1.27% |
172,822
+3,634
| +2% | +$102K |
|
28
Sherwin-Williams
SHW
$90B
| $4.81M | 1.26% |
13,782
-252
| -2% | -$88K |
|
29
Fidelity Blue Chip Growth ETF
FBCG
$4.59B
| $4.75M | 1.24% |
118,759
-3,660
| -3% | -$146K |
|
30
Palantir
PLTR
$373B
| $4.65M | 1.22% |
55,105
-859
| -2% | -$72.5K |
|
|
31
Tesla
TSLA
$1.06T
| $4.48M | 1.17% |
+17,268
| New | +$4.48M |
|
|
32
Berkshire Hathaway Class B
BRK.B
$1.08T
| $4.37M | 1.14% |
8,203
+5,865
| +251% | +$3.12M |
|
|
33
TransDigm Group
TDG
$73.5B
| $4.22M | 1.11% |
3,053
-2,864
| -48% | -$3.96M |
|
34
Datadog
DDOG
$47B
| $3.99M | 1.04% |
40,189
-16,317
| -29% | -$1.62M |
|
35
Ball Corp
BALL
$13.9B
| $3.97M | 1.04% |
76,196
| – | – |
|
|
36
JPMorgan Chase
JPM
$824B
| $3.33M | 0.87% |
+13,573
| New | +$3.33M |
|
37
Applovin
APP
$163B
| $3.2M | 0.84% |
12,075
-176
| -1% | -$46.6K |
|
38
Booking.com
BKNG
$178B
| $3M | 0.79% |
+651
| New | +$3M |
|
39
KKR & Co
KKR
$124B
| $2.95M | 0.77% |
+25,545
| New | +$2.95M |
|
40
Texas Roadhouse
TXRH
$11.4B
| $2.95M | 0.77% |
+17,690
| New | +$2.95M |
|
41
United Therapeutics
UTHR
$18.3B
| $2.93M | 0.77% |
9,498
-189
| -2% | -$58.3K |
|
|
42
Vertex Pharmaceuticals
VRTX
$103B
| $2.91M | 0.76% |
5,996
-10,927
| -65% | -$5.3M |
|
43
Schwab U.S Small- Cap ETF
SCHA
$18.5B
| $2.82M | 0.74% |
120,149
+1,517
| +1% | +$35.5K |
|
44
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
| $2.19M | 0.57% |
18,670
-1,278
| -6% | -$150K |
|
45
Vanguard Value ETF
VTV
$143B
| $1.9M | 0.5% |
10,977
+462
| +4% | +$79.8K |
|
46
Invesco QQQ Trust
QQQ
$361B
| $1.84M | 0.48% |
3,927
+34
| +0.9% | +$15.9K |
|
47
AbbVie
ABBV
$374B
| $1.21M | 0.32% |
5,763
-1,800
| -24% | -$377K |
|
48
Johnson & Johnson
JNJ
$429B
| $1.2M | 0.31% |
7,207
-4
| -0.1% | -$663 |
|
49
Vanguard S&P 500 ETF
VOO
$720B
| $1.18M | 0.31% |
2,301
+407
| +21% | +$209K |
|
50
Procter & Gamble
PG
$370B
| $953K | 0.25% |
5,591
-19
| -0.3% | -$3.24K |
|